DoW Peer Reviewed Cancer, Clinical Trial Award
Funds cancer clinical trials from first-in-human through phase III, with regulatory filings already due at the application deadline.
About
A treatment idea that has cleared the lab still has to prove itself in people, and the biggest single mechanism in this programme's cancer portfolio exists to move that step along fast.
The award funds clinical trials with real potential to change how cancer is treated or managed, inside at least one of the programme's FY26 Topic Areas. What counts as a trial here is broad — new products, drugs o…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.